Document is current
Any future updates will be listed below
-
Authors
Rothhammer, Veit
Quintana, Francisco J. http://orcid.org/0000-0001-8156-0736
- License Information
-
More Information
Article History
First Online: 4 February 2019
Competing interests
: F.J.Q. is a founder of AnTolRx, a company exploring the targeting of aryl hydrocarbon receptor (AHR) with nanoparticles for the treatment of inflammatory conditions. He is also a scientific adviser for Kyn Therapeutics, a company exploring targeting AHR for cancer therapy.
